Skip to content
JournalsWorldThe Global Research Discovery Platform
Login Sign Up

Academic Journal

Q1

Journal of Liver Cancer

rakibul2237@gmail.com

South KoreaHepatology (Q1); Oncology (Q1); Pathology and Forensic Medicine (Q1); Surgery (Q1)ISSN-matched source record
Submission information ↗
Q1Ranking
—Impact Factor (year unverified)
15H-index (SCImago 2025)
1.672SJR (2025)
2019-2025Coverage

About Journal of Liver Cancer

About Journal of Liver Cancer

Journal of Liver Cancer is a peer-reviewed scholarly journal (South Korea). It focuses on Q1. Publication coverage spans 2019-2025.

Key indicators: ISSN 2288-8128, 2383-5001; H-index 15.

Understanding This Journal's Metrics

Journal metrics help researchers assess fit, but they must be interpreted in context:

  • H-index (15): 15 articles have each received at least 15 citations, indicating growing recognition.

Publishing in Journal of Liver Cancer

When considering this journal, verify its current indexing status, editorial board, and recent publications to ensure it meets your needs for visibility and credibility.

  • Scope fit: Confirm your research aligns with Q1. Off-scope manuscripts are typically desk-rejected quickly.
  • Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.

Is This Journal Right for Your Paper?

  • Audience match: Will the journal's readers cite and build on your findings?
  • Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
  • Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
  • Open access needs: Check funder mandates and whether the journal offers compliant OA options.

Frequently Asked Questions

What is the ISSN of Journal of Liver Cancer?
2288-8128, 2383-5001.

What are Journal of Liver Cancer's metrics?
H-index 15.

Is Journal of Liver Cancer peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.

Open-access policies and author information

Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2022-02-15. This snapshot does not establish today’s listing status or fee quotation.

Accepted manuscript languagesEnglish
Licence optionsCC BY-NC
Peer-review processAnonymous peer review
APCNo APC reported in the DOAJ snapshot
Waiver policy reportedNo
Other fees reportedNo
Author retains unrestricted copyrightNo
Reported submission-to-publication time12 weeks on average; not a guarantee
Openly licensed content since2015 (not the journal founding year)

Publisher policy links recorded by DOAJ

Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.

Source-backed journal facts

ISSN(s)2288-8128, 2383-5001
ISSN-L2288-8128
Source typeJournal
Publisher country codeKR
Fully open access (OpenAlex)Yes
DOAJ flag (OpenAlex)Listed in OpenAlex metadata; confirm current status in DOAJ
Works recorded in OpenAlex374
Citations recorded in OpenAlex1,749
OpenAlex H-index21
Years represented in OpenAlex1988–2026 (not the founding or closing dates)

Topics in published research

Hepatocellular Carcinoma Treatment and Prognosis; Liver Disease Diagnosis and Treatment; Cholangiocarcinoma and Gallbladder Cancer Studies; Cancer Mechanisms and Therapy; Hepatitis B Virus Studies; Liver Disease and Transplantation.

OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.

Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.

Found incorrect or outdated information?Help us keep this profile accurate.
Suggest an Edit